← Back to Search

Procedure

MCG Device for Acute Coronary Syndrome (DUET Trial)

N/A
Waitlist Available
Research Sponsored by SB Technology, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Having an active atrial fibrillation episode as seen on 12-lead ECG
Present STEMI
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-days
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new device called SandboxAQ MCG to see if it can accurately and quickly measure heart disease in patients with high Troponin levels in a hospital setting.

Who is the study for?
This trial is for patients who have been diagnosed with Acute Coronary Syndrome and are currently in a hospital setting. They must have elevated Troponin levels, which indicate heart muscle damage.
What is being tested?
The study is testing the use of a new Magnetocardiography (MCG) device by SandboxAQ to see if it can quickly and accurately measure heart disease in patients with high Troponin levels.
What are the potential side effects?
Since this trial involves data collection using an MCG device rather than medication or invasive procedures, there are no direct side effects associated with its use.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I currently have atrial fibrillation, confirmed by an ECG.
Select...
I have had a severe heart attack recently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion (%) of all collected MCG data that meets the necessary data quality. requirements and are deemed suitable for analysis.
Secondary study objectives
Sandbox MCG safety

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sponsor MCG DeviceExperimental Treatment1 Intervention
All participants will receive a scan from the sponsor's MCG device.

Find a Location

Who is running the clinical trial?

SB Technology, Inc.Lead Sponsor
2 Previous Clinical Trials
250 Total Patients Enrolled
Kit Yee Au-Yeung, PhDStudy DirectorSB Technology, Inc.
2 Previous Clinical Trials
250 Total Patients Enrolled
~20 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top